7210 Research and experimental development on natural sciences and engineering

Provider of pharmaceutical drug development services that encompass the entire process from discovery through commercialization.

Antibody drug discovery.

Clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer.

Biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery.

Independent clinical research sites that manage clinical trials for pharmaceuticals, clinical research organizations, and biotechs.

Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases.

Novel therapeutics company for neurodegenerative diseases caused by defective energy metabolism in the brain.

Provider of Accelerator Mass Spectrometry (AMS) bioanalytical services in North America.

Develops solutions to the problem of drug resistance

Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.

Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment.

A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders.

A biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of inflammatory diseases.

Drug development services

Therapeutics and diagnostics for Alzheimer's disease.

A biopharmaceutical company, develops specialty therapeutics to enhance patient outcomes in infectious diseases, transplant, and ICU areas.

An innovative antibody engineering technology company in China.

Rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples.

Developer of a human antibody discovery platform in yeast.

A biotechnology company focused on developing new class of therapeutic compounds.

Develops rapid diagnostic tools to detect and manage disease states, reproductive, nutritional and overall health status of livestock animals.

An industry leader in the science of regenerative medicine

Monitoring for individuals to improve their health; increase peace of mind.

Biotechnology company developing an automated approach for obtaining very large numbers of antibodies.

A biotechnology company that discovers and develops drugs to treat central nervous system disorders.

Biopharmaceutical company focused on the development of novel transdermal products addressing women's health.

Agricultural biotechnology company formed to improve the sustainability and efficiency of crop production agriculture.

Developer of peptide coatings for medical application.

Provider of data to the healthcare industry.

Disease management company specializing in respiratory disorders.

Provides critical support to new bioventures during the first stages of the technology-to-business translation process.

Developer of antibody therapeutics.

Montreal-based biotechnology company

Complement inhibition for cardiovascular and inflammatory diseases.

Innovative hybrid clean-tech/ bio-tech company.

Allegro Diagnostics Corp. is a molecular diagnostics company.

Develops and commercializes transdermal drug delivery systems.

A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension.

A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer.

A clinical stage biopharmaceutical company with a broad biologics platform that allows it to create best-in-class protein therapeutics.

Develops the world's most comprehensive, accurate, and transparent calculation engine for quantifying Greenhouse Gases (GHGs).

A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology.

A NeoStem company, develops cell therapy products to treat cardiovascular disease.

Development and commercialization of innovative therapies for the prevention and treatment of diseases.

A structure-based drug discovery business specialising in diseases such as osteoporosis, osteoarthritis, bone metasta. Secondary sale in February 2005

Developing a novel class of protein therapeutics, Atrimers, to address significant unmet medical needs in immune-mediated diseases and oncology.

Antibody therapeutics company focusing on antibody discovery and optimization.

Therapeutics and provide preclinical testing assays.

Biotechnology company developing products for peripheral and cardiac ischemia.

Drug development utilizing cell targeting technology

A biotechnology company focused on technology and products to treat cancers, infectious diseases, and autoimmune disorders.

Investing company

A UK-based developer of synthetic bone grafts. Acquired by Baxter International Inc, US healthcare giant, for $330m in March 2010.

Biotechnology company focused on developing innovative therapeutics, primarily in the area of severe asthma and chronic obstructive pulmonary disease

A discovery platform technology focused on APE1/Ref1 pathway to produce a series of novel compounds for cancer treatment.

A clinical stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology.

A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus.